10X Capital Venture Acquisition Corp. III financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
1 World Trade Center, Floor 85, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 27, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.18 % -97.8%
Debt-to-equity -516 % -385%
Return On Equity 7.62 %
Return On Assets -1.13 % -513%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 303M USD
Common Stock, Value, Issued 115 USD

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 8.13M USD +817%
Operating Income (Loss) -8.55M USD -598%
Net Income (Loss) Attributable to Parent -1.25M USD -298%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 825K USD +261%
Assets 44M USD -85.7%
Accounts Payable, Current 823K USD +268%
Accrued Liabilities, Current 75K USD -62.7%
Liabilities, Current 5.52M USD +1347%
Liabilities 19.8M USD +35.1%
Retained Earnings (Accumulated Deficit) -18.9M USD -31.7%
Stockholders' Equity Attributable to Parent -18.9M USD -31.7%
Liabilities and Equity 44M USD -85.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 208K USD
Net Cash Provided by (Used in) Financing Activities -267M USD -187%
Net Cash Provided by (Used in) Investing Activities 267M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 647K USD +406%
Cash and Cash Equivalents, Period Increase (Decrease) 672K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%